Raymond James & Associates »

Neurocrine Biosciences shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.3M 60k 137.92
2023-12-31 $7.7M 58k 131.76
2023-09-30 $6.6M 59k 112.50
2023-06-30 $5.6M 60k 94.30
2023-03-31 $7.9M 78k 101.22
2022-12-31 $9.3M 78k 119.44
2022-09-30 $7.7M 72k 106.22
2022-06-30 $6.3M 65k 97.48
2022-03-31 $7.5M 80k 93.75
2021-12-31 $5.6M 66k 85.17
2021-09-30 $15M 153k 95.91
2021-06-30 $16M 162k 97.32
2021-03-31 $18M 181k 97.25
2020-12-31 $18M 190k 95.85
2020-09-30 $11M 112k 96.16
2020-06-30 $13M 108k 122.00
2020-03-31 $8.4M 98k 86.55
2019-12-31 $10M 94k 107.49
2019-09-30 $8.1M 90k 90.11
2019-06-30 $6.3M 75k 84.43
2019-03-31 $5.0M 57k 88.10
2018-12-31 $2.1M 29k 71.40
2018-09-30 $4.7M 38k 122.95
2018-06-30 $1.0M 10k 98.24
2018-03-31 $770k 9.3k 82.94
2017-12-31 $708k 9.1k 77.58
2017-09-30 $1.4M 23k 61.30
2017-06-30 $337k 7.3k 45.98
2017-03-31 $382k 8.8k 43.26
2016-12-31 $528k 14k 38.69
2016-09-30 $989k 20k 50.64
2016-06-30 $409k 9.0k 45.48
2016-03-31 $362k 9.2k 39.54
2015-12-31 $593k 11k 56.57